Q2 2024 · 13F-HR
Pennant Investors, LPholdings as filed
Filed 2024-08-14 · accession 0000919574-24-004628
$382.6M
Reported value
46
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 595112103 | MU | MICRON TECHNOLOGY INC | $56.7M | 14.8% | 431,000 | Common | SOLE |
| 023135106 | AMZN | AMAZON COM INC | $46.4M | 12.1% | 240,000 | Common | SOLE |
| 893641100 | TDG | TRANSDIGM GROUP INC | $41.4M | 10.8% | 32,371 | Common | SOLE |
| 278768106 | SATS | ECHOSTAR CORP | $38.3M | 10.0% | 2,153,209 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $35.8M | 9.35% | 80,000 | Common | SOLE |
| 02079K305 | GOOGL | ALPHABET INC | $33.3M | 8.71% | 183,000 | Common | SOLE |
| 03674X106 | AR | ANTERO RESOURCES CORP | $27.3M | 7.13% | 836,000 | Common | SOLE |
| L7579L106 | — | PERIMETER SOLUTIONS SA | $18.0M | 4.71% | 2,300,000 | Common | SOLE |
| 03674X106 | AR | ANTERO RESOURCES CORP | $16.3M | 4.26% | 500,000 | CALL | SOLE |
| 88337F105 | ODP1 | THE ODP CORP | $15.7M | 4.11% | 400,000 | Common | SOLE |
| 920253101 | VMI | VALMONT INDS INC | $11.0M | 2.87% | 40,000 | Common | SOLE |
| 36828A101 | GEV | GE VERNOVA INC | $10.3M | 2.69% | 60,000 | Common | SOLE |
| 92537N108 | VRT | VERTIV HOLDINGS CO | $10.0M | 2.60% | 115,000 | Common | SOLE |
| Q4982L109 | IREN | IRIS ENERGY LTD | $5.3M | 1.39% | 470,000 | Common | SOLE |
| 21874A106 | CORZ | CORE SCIENTIFIC INC NEW | $4.7M | 1.22% | 500,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.6M | 0.42% | 170,900 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $1.2M | 0.31% | 56,800 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $763,398 | 0.20% | 60,300 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $730,170 | 0.19% | 109,800 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $685,643 | 0.18% | 768,400 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $651,112 | 0.17% | 15,100 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $479,208 | 0.13% | 146,100 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $458,676 | 0.12% | 55,800 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $455,247 | 0.12% | 35,100 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $445,863 | 0.12% | 64,900 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $392,232 | 0.10% | 166,200 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $360,951 | 0.09% | 23,700 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $356,445 | 0.09% | 44,500 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $329,337 | 0.09% | 38,700 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $318,985 | 0.08% | 13,100 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $299,172 | 0.08% | 128,400 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $290,813 | 0.08% | 168,100 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $276,448 | 0.07% | 42,400 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $274,500 | 0.07% | 30,500 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $217,280 | 0.06% | 48,500 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $211,567 | 0.06% | 292,300 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $199,000 | 0.05% | 199,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $190,050 | 0.05% | 17,500 | Common | SOLE |
| 37427G101 | GETR | GETAROUND INC | $188,741 | 0.05% | 1,348,153 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $186,150 | 0.05% | 43,800 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $186,100 | 0.05% | 186,100 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $156,016 | 0.04% | 215,700 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $132,516 | 0.03% | 32,400 | Common | SOLE |
| 09075P105 | BTAIEUR | BIOXCEL THERAPEUTICS INC | $107,392 | 0.03% | 83,900 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $86,019 | 0.02% | 87,400 | Common | SOLE |
| G4124C117 | GRABW | GRAB HOLDINGS LIMITED | $12,888 | 0.00% | 80,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.